Friday, April 19, 2013

TIME Magazine's latest 2013 Top 100 Most Influential People edition features Grupo Vidanta and its founder Mr. Daniel Chavez Moran

Mexican resort specialist Grupo Vidanta is gearing up to launch six new luxury brands throughout Latin America.  A visionary group that has contributed to the socioeconomic development of Mexico for more than 35 years, Vidanta invests in some of the region’s most spectacular vacation destinations, responding to market demands with stunning, state-of-the-art establishments.


Two of its brands, the Grand Mayan, which is present in Nuevo Vallarta, Acapulco, Riviera Maya and Los Cabos, the Grand Bliss, in Nuevo Vallarta, have earned the AAA Four Diamond Award for delivering a luxurious experience with top-notch services and amenities.  “Mexico is the land of opportunity”, says Vidanta founder Daniel Chavez Moran.  “Even if we were not Mexican, we would invest in Mexico, because it is about to take off in a big way.  The workforce here is second to none.  We employ around 14,000 workers, and this year were voted eighth-best company to work for.  Our employees are more than happy with us, and this filters down to the service provision.”

With its aim of keeping its sites exclusive, Vidanta veers away from the all-inclusive concept, believing that a quality service offering best value will be most beneficial for its guests.  “We are often full or at least at 80% occupancy throughout the year, so it’s a good strategy and ultimately the most profitable,” Chavez Moran says.  “We are currently building more than 120,000 square meters a year, which works out at between 500 and 600 rooms of 200 meters a year.  Our prices are not the lowest in the industry, but we’re sure they offer the best value for the money.

“As a businessman, I would say to investors: ‘Stay where you are, I don’t want any more competitors’’.  But as a Mexican, I would tell them to come,” Chavez Moran says.  Mexico is the best place in the world and now offers the opportunity of a lifetime.”


No comments:

Post a Comment